Finance entity
earnings is the sole category represented across all 1 tracked stories. GoodRx is most often covered alongside Celsius Holdings, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 12 original sources each against 2.6 for the same window.
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. GoodRx is most often covered alongside Celsius Holdings, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 12 original sources each against 2.6 for the same window. Their average consequence score of 5 runs below the beat's 6 for that window. We currently track 1 Finance story that mention GoodRx, all published on February 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 120 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GoodRx. Shared-story counts are live from our verified record — not editorial picks.
Payoneer reported robust Q4 2025 results, driven by double-digit growth in B2B volume and strategic expansion into emerging markets. The broader mid-cap landscape shows a divergence between high-growth consumer brands like Celsius and R&D-heavy biotech firms navigating a complex regulatory environment.
GoodRx is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
